10-Q Filing

PRIVIA HEALTH GROUP, INC. CIK: 1759655 Q2 2023

Filing Information

Form Type	10-Q
Accession Number	`0001759655-23-000190`
Period End Date	20230630
Filing Date	20230803
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	prva-20230630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 69 Income Statement 74 Cash Flow Statement 64 Stockholders Equity 34

Balance Sheet 69 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	117.11M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	114.69M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$317.94M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$347.99M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	114.69M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	117.11M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$189.60M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$319.84M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$16.22M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$14.37M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$551.96M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$654.00M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.88M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.39M	USD	Point-in-time
Right-of-use asset	`OperatingLeaseRightOfUseAsset`	$8.09M	USD	Point-in-time
Right-of-use asset	`OperatingLeaseRightOfUseAsset`	$7.55M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$96.24M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$57.39M	USD	Point-in-time
Goodwill	`Goodwill`	$135.05M	USD	Point-in-time
Goodwill	`Goodwill`	$126.94M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$37.11M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$40.37M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.68M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.75M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$240.85M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$283.57M	USD	Point-in-time
Total assets	`Assets`	$937.57M	USD	Point-in-time
Total assets	`Assets`	$792.81M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$52.84M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$48.87M	USD	Point-in-time
Provider liability	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$208.42M	USD	Point-in-time
Provider liability	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$306.37M	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	$3.21M	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	$3.01M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$358.44M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$264.27M	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	$6.51M	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	$8.49M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.31M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.00M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$7.82M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$9.49M	USD	Point-in-time
Total liabilities	`Liabilities`	$366.26M	USD	Point-in-time
Total liabilities	`Liabilities`	$273.76M	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value, 1,000,000,000 and 1,000,000,000 shares authorized; 117,106,892 and 114,690,808 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$1.15M	USD	Point-in-time
Common stock, $0.01 par value, 1,000,000,000 and 1,000,000,000 shares authorized; 117,106,892 and 114,690,808 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$1.17M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$726.16M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$714.64M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-216.69M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-202.09M	USD	Point-in-time
Total Privia Health Group, Inc. stockholders equity	`StockholdersEquity`	$499.09M	USD	Point-in-time
Total Privia Health Group, Inc. stockholders equity	`StockholdersEquity`	$525.23M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$46.08M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$19.95M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$556.52M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$450.18M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$571.31M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$467.11M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$519.05M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$457.90M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$792.81M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$937.57M	USD	Point-in-time

Income Statement 74 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$799.63M	USD	2 Qtrs
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$649.34M	USD	2 Qtrs
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$413.35M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$335.54M	USD	1 Quarter
Provider expense	`LiabilityForFuturePolicyBenefitsPeriodExpense`	$501.50M	USD	2 Qtrs
Provider expense	`LiabilityForFuturePolicyBenefitsPeriodExpense`	$623.97M	USD	2 Qtrs
Provider expense	`LiabilityForFuturePolicyBenefitsPeriodExpense`	$259.31M	USD	1 Quarter
Provider expense	`LiabilityForFuturePolicyBenefitsPeriodExpense`	$321.72M	USD	1 Quarter
Cost of platform	`CostOfPlatform`	$42.38M	USD	1 Quarter
Cost of platform	`CostOfPlatform`	$50.20M	USD	1 Quarter
Cost of platform	`CostOfPlatform`	$94.93M	USD	2 Qtrs
Cost of platform	`CostOfPlatform`	$83.66M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$4.82M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$9.48M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$11.24M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$5.96M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$26.81M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$52.76M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$33.11M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$69.22M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.17M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.28M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.03M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.69M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$406.37M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$785.93M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$340.79M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$666.13M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$-5.25M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$6.98M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-16.80M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$13.69M	USD	2 Qtrs
Interest (income) expense, net	`InterestIncomeExpenseNet`	$817.00K	USD	1 Quarter
Interest (income) expense, net	`InterestIncomeExpenseNet`	$-663.00K	USD	1 Quarter
Interest (income) expense, net	`InterestIncomeExpenseNet`	$2.63M	USD	2 Qtrs
Interest (income) expense, net	`InterestIncomeExpenseNet`	$-895.00K	USD	2 Qtrs
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$16.32M	USD	2 Qtrs
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-17.69M	USD	2 Qtrs
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$7.80M	USD	1 Quarter
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.91M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$11.78M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$5.47M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.44M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$3.56M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-18.09M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$6.36M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$6.40M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$12.76M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-29.47M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-11.38M	USD	1 Quarter
Less: loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.84M	USD	2 Qtrs
Less: loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-906.00K	USD	1 Quarter
Less: loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-914.00K	USD	1 Quarter
Less: loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.48M	USD	2 Qtrs
Net income (loss) attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$14.60M	USD	2 Qtrs
Net income (loss) attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$7.27M	USD	1 Quarter
Net income (loss) attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$-10.47M	USD	1 Quarter
Net income (loss) attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$-27.98M	USD	2 Qtrs
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$0.06	USD	1 Quarter
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$-0.10	USD	1 Quarter
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$0.13	USD	2 Qtrs
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$-0.26	USD	2 Qtrs
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.10	USD	1 Quarter
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.12	USD	2 Qtrs
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.06	USD	1 Quarter
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.26	USD	2 Qtrs
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	108.37M	shares	2 Qtrs
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	108.69M	shares	1 Quarter
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	116.16M	shares	1 Quarter
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	115.59M	shares	2 Qtrs
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	124.57M	shares	1 Quarter
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	108.37M	shares	2 Qtrs
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	124.47M	shares	2 Qtrs
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	108.69M	shares	1 Quarter

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-18.09M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$6.36M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$6.40M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$12.76M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-29.47M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-11.38M	USD	1 Quarter
Depreciation	`Depreciation`	$615.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$581.00K	USD	2 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.67M	USD	2 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.40M	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$2.45M	USD	2 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$900.00K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationAdditionOfDebtIssuanceCosts`	-	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationAdditionOfDebtIssuanceCosts`	$687.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$43.35M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$14.63M	USD	2 Qtrs
Deferred tax expense	`DeferredIncomeTaxExpenseBenefit`	$11.54M	USD	2 Qtrs
Deferred tax expense	`DeferredIncomeTaxExpenseBenefit`	$3.26M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$130.24M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$96.49M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.85M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$6.49M	USD	2 Qtrs
Other non-current assets and right-of-use asset	`IncreaseDecreaseInOtherNoncurrentAssets`	$-2.23M	USD	2 Qtrs
Other non-current assets and right-of-use asset	`IncreaseDecreaseInOtherNoncurrentAssets`	$-473.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayable`	$-3.97M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayable`	$-5.65M	USD	2 Qtrs
Provider liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$81.17M	USD	2 Qtrs
Provider liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$97.94M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.79M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.26M	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-32.00K	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	2 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.78M	USD	2 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.90M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$73.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$72.00K	USD	2 Qtrs
Business Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Business Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$24.86M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-73.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-24.93M	USD	2 Qtrs
Repayment of note payable	`RepaymentsOfNotesPayable`	$33.25M	USD	2 Qtrs
Repayment of note payable	`RepaymentsOfNotesPayable`	-	USD	2 Qtrs
Proceeds from exercised stock options	`ProceedsFromStockOptionsExercised`	$5.78M	USD	2 Qtrs
Proceeds from exercised stock options	`ProceedsFromStockOptionsExercised`	$2.92M	USD	2 Qtrs
Repurchase of non-controlling interest	`PaymentsToMinorityShareholders`	-	USD	2 Qtrs
Repurchase of non-controlling interest	`PaymentsToMinorityShareholders`	$5.69M	USD	2 Qtrs
Proceeds from non-controlling interest	`ProceedsFromMinorityShareholders`	$569.00K	USD	2 Qtrs
Proceeds from non-controlling interest	`ProceedsFromMinorityShareholders`	$125.00K	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-30.21M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$658.00K	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-28.38M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-30.05M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$292.19M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$317.94M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$320.58M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$347.99M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$292.19M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$317.94M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$320.58M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$347.99M	USD	Point-in-time
Interest paid	`InterestPaidNet`	$647.00K	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$57.00K	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$599.00K	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$245.00K	USD	2 Qtrs

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Beginning balance (in shares)	`CommonStockSharesOutstanding`	114.69M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	117.11M	shares	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$556.52M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$450.18M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$571.31M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$467.11M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$519.05M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$457.90M	USD	Point-in-time
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueShareBasedCompensation`	$799.00K	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.48M	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueShareBasedCompensation`	$4.31M	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueShareBasedCompensation`	$2.12M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$18.47M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$24.88M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.38M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$9.25M	USD	1 Quarter
Repurchase of non-controlling interest	`MinorityInterestDecreaseFromRedemptions`	$5.69M	USD	1 Quarter
Contributed non-controlling interest	`NoncontrollingInterestIncreaseFromBusinessCombination`	$569.00K	USD	1 Quarter
Contributed non-controlling interest	`NoncontrollingInterestIncreaseFromBusinessCombination`	$24.21M	USD	1 Quarter
Contributed non-controlling interest	`NoncontrollingInterestIncreaseFromBusinessCombination`	$125.00K	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-18.09M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$6.36M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$6.40M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$12.76M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$-29.47M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$-11.38M	USD	1 Quarter
Ending balance (in shares)	`CommonStockSharesOutstanding`	114.69M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	117.11M	shares	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$556.52M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$450.18M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$571.31M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$467.11M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$519.05M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$457.90M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.